Parenteral Nutrition Market Size, Share & Forecast Analysis to 2030

The global parenteral nutrition market size was valued at around USD 8 billion in 2026 and projected to grow at a significant CAGR of around 6% during the forecast period from 2026 to 2030. The market is driven by the increasing prevalence of gastrointestinal disorders, cancer, and other chronic conditions that require intravenous nutritional support when oral or enteral feeding is not possible. The growing adoption of home parenteral nutrition, along with advancements in portable infusion devices and customized nutrition formulations, is creating new avenues for market expansion. North America holds the largest market share due to its well-established healthcare infrastructure, favorable reimbursement policies, high adoption of advanced clinical nutrition therapies, and the presence of leading industry participants.

Market Snapshot:

Key Insights:

• North America accounted for the largest share of the global parenteral nutrition market, supported by advanced healthcare infrastructure and high adoption of clinical nutrition therapies.
• Amino acids dominated the nutrient type segment due to their essential role in protein synthesis, tissue repair, and recovery among critically ill patients.
• Cancer represented the leading indication segment owing to the high incidence of malnutrition and increasing demand for nutritional support during oncology treatment.
• Hospitals remained the dominant end-user segment because of the large volume of intensive care, surgical, neonatal, and oncology patients requiring parenteral nutrition.
• Continuous advancements in personalized nutrition formulations, ready-to-use products, and home infusion technologies are reshaping the competitive landscape and supporting long-term market growth.

Key Factors Driving the Parenteral Nutrition Market Growth

The increasing prevalence of gastrointestinal disorders, short bowel syndrome, inflammatory bowel disease, cancer, and other chronic illnesses is a major factor driving the parenteral nutrition market. Patients who are unable to obtain adequate nutrition through the gastrointestinal tract rely on parenteral nutrition to meet their nutritional requirements, particularly in intensive care, oncology, and neonatal settings. The rising aging population and increasing incidence of disease-related malnutrition are further supporting demand for advanced parenteral nutrition therapies.

Continuous product innovation and improvements in manufacturing capabilities are also accelerating market growth. In February 2025, Baxter International Inc. announced that its North Cove manufacturing facility had returned to pre-Hurricane Helene production levels, restoring the supply of critical intravenous nutrition and hospital products, including parenteral nutrition solutions, to healthcare providers. This recovery is expected to strengthen product availability and support the growing demand for clinical nutrition worldwide.

Key Growth Drivers:

• Increasing prevalence of gastrointestinal disorders, cancer, and chronic diseases is driving demand for parenteral nutrition across hospitals and critical care settings.
• Growing adoption of home parenteral nutrition and advanced infusion technologies is improving patient convenience and expanding long-term treatment options.
• Rising geriatric population and increasing number of premature births are fueling the need for specialized intravenous nutritional support worldwide.

Parenteral Nutrition Market Restraints

The high cost of parenteral nutrition therapy and associated hospitalization remains a significant challenge for market growth. Treatment often requires specialized formulations, infusion equipment, trained healthcare professionals, and continuous patient monitoring, increasing the overall cost of care. These expenses can limit access to parenteral nutrition, particularly in low- and middle-income countries where healthcare budgets and reimbursement coverage are limited.

Another major restraint is the risk of complications associated with long-term parenteral nutrition, including catheter-related bloodstream infections, liver dysfunction, metabolic abnormalities, and electrolyte imbalances. These potential adverse effects require careful clinical supervision and regular monitoring, which can discourage prolonged use and increase the burden on healthcare providers and patients.

Growth Opportunities in the Global Parenteral Nutrition Market

The growing preference for home-based healthcare is creating new opportunities in the parenteral nutrition market. Increasing adoption of home parenteral nutrition, supported by portable infusion systems, telehealth services, and personalized nutrition formulations, is enabling patients with chronic gastrointestinal disorders to receive long-term nutritional support outside hospital settings while improving treatment convenience.

Another opportunity lies in the development of advanced lipid emulsions and pediatric nutrition therapies that improve clinical outcomes and expand treatment options. In February 2024, the U.S. Food and Drug Administration (FDA) approved updated prescribing information for Intralipid 30% (lipid injectable emulsion), introducing revised dosing and administration guidance for parenteral nutrition in adult and pediatric patients, reflecting continued advancements in intravenous nutrition therapies.

Key Growth Opportunities:

• Rising adoption of home parenteral nutrition is creating opportunities for portable infusion systems and remote patient monitoring solutions.
• Increasing investments in advanced lipid emulsions and personalized nutrition formulations are expanding treatment options across diverse patient populations.
• Growing healthcare infrastructure in emerging economies is accelerating access to specialized clinical nutrition therapies and improving market penetration.

Industry Trends Shaping the Global Parenteral Nutrition Market

The parenteral nutrition market is witnessing a growing shift toward personalized nutrition and home-based infusion therapy, enabling healthcare providers to deliver tailored nutritional support for patients with chronic gastrointestinal disorders and long-term nutritional deficiencies. The increasing use of ready-to-use multi-chamber bags and digital patient monitoring is further improving treatment efficiency and patient outcomes. In addition, hospitals are increasingly adopting standardized parenteral nutrition protocols to reduce medication errors, enhance patient safety, and optimize clinical workflows.

Another notable trend is the strengthening of manufacturing capacity for intravenous nutrition products to improve supply chain resilience. In October 2024, Fresenius Kabi announced that it was evaluating accelerated production of IV solutions at its Wilson, North Carolina facility in collaboration with the U.S. FDA to help address nationwide shortages of hospital infusion products following Hurricane Helene. This reflects the industry’s increasing focus on ensuring a reliable supply of critical intravenous therapies, including products used in parenteral nutrition.

Market Segments Insights:

By Nutrient Type: The Amino Acids Segment Dominated the Global Parenteral Nutrition Market

On the basis of nutrient type, the amino acids hold the largest share of the parenteral nutrition market due to their essential role in protein synthesis, tissue repair, immune function, and recovery of critically ill patients. Amino acid formulations are widely administered across intensive care units, oncology, neonatal, and postoperative care settings to prevent muscle wasting and maintain nitrogen balance in patients unable to receive enteral nutrition. For instance, the American Society for Parenteral and Enteral Nutrition (ASPEN) recommends appropriate amino acid dosing as a core component of parenteral nutrition therapy to preserve lean body mass and improve clinical outcomes in critically ill patients.

Carbohydrates represent a significant segment as they provide the primary source of energy in parenteral nutrition formulations. Lipid Emulsions are witnessing steady growth owing to their ability to supply concentrated calories and essential fatty acids while reducing excessive glucose administration. Vitamins & Minerals and Electrolytes remain indispensable for maintaining metabolic functions, fluid balance, and organ health during intravenous nutrition therapy. The Others segment, including trace elements and specialty additives, continues to expand with the increasing adoption of personalized and disease-specific parenteral nutrition formulations.

By Indication: The Cancer Sub-category Holds the Largest Share of Global Parenteral Nutrition Market

On the basis of indication, the cancer accounted for the largest share of the parenteral nutrition market owing to the high prevalence of malnutrition, cachexia, chemotherapy-induced gastrointestinal complications, and postoperative nutritional requirements among oncology patients. Parenteral nutrition plays a critical role in maintaining nutritional status when oral or enteral feeding is not feasible, helping improve treatment tolerance and recovery. Supporting this trend, the European Society for Clinical Nutrition and Metabolism (ESPEN) recommends parenteral nutrition for cancer patients when nutritional requirements cannot be adequately met through oral or enteral intake.

Gastrointestinal Disorders represent another major segment due to the increasing incidence of short bowel syndrome, inflammatory bowel disease, intestinal failure, and severe malabsorption. Neurological Disorders contribute to market growth as patients with stroke, Parkinson’s disease, and other neurological conditions often require intravenous nutritional support because of swallowing difficulties. Diabetes remains an important segment where specialized parenteral nutrition formulations help manage hospitalized patients requiring nutritional therapy. The Critical Care segment is expanding steadily with rising ICU admissions, trauma cases, and major surgeries requiring intensive nutritional support, while the Others segment includes neonatal care, severe burns, pancreatitis, and other conditions requiring long-term parenteral nutrition.

Global Parenteral Nutrition Market Segmentation:

By Nutrient Type:

• Carbohydrates
• Amino Acids
• Lipid Emulsions
• Vitamins & Minerals
• Electrolytes
• Others

By Indication:

• Cancer
• Gastrointestinal Disorders
• Neurological Disorders
• Diabetes
• Critical Care
• Others

By Age Group:

• Pediatric
• Adult
• Geriatric

By End-User:

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis: The North America Leading the Global Parenteral Nutrition Market

Geographically, the North America holds the largest share of the global parenteral nutrition market due to its advanced healthcare infrastructure, high prevalence of chronic diseases, and widespread adoption of clinical nutrition therapies across hospitals and home healthcare settings. The region also benefits from favorable reimbursement policies, strong clinical nutrition awareness, and the presence of leading manufacturers offering a broad portfolio of parenteral nutrition products.

The region’s leadership is further supported by its well-established home parenteral nutrition (HPN) programs and specialized intestinal rehabilitation centers. In 2024, a review published in the American Journal of Health-System Pharmacy highlighted the continued expansion of long-term home parenteral nutrition programs, emphasizing multidisciplinary care, improved vascular access management, and advances in patient monitoring that are enhancing long-term outcomes for patients dependent on parenteral nutrition.

Competitive Analysis:

The parenteral nutrition market is moderately consolidated, with leading companies such as Baxter International Inc., B. Braun SE, Fresenius Kabi AG, Grifols S.A., and Otsuka Pharmaceutical Co., Ltd. accounting for a significant share of the global market. These companies are focused on expanding manufacturing capacity, strengthening distribution networks, and developing advanced parenteral nutrition formulations to address the growing demand from hospitals and home healthcare providers.

Competition is driven by continuous product innovation, regulatory approvals, strategic collaborations, and geographic expansion across developed and emerging markets. Manufacturers are prioritizing ready-to-use multi-chamber bags, improved lipid emulsions, customized nutritional formulations, and enhanced sterile manufacturing capabilities to strengthen their competitive position while ensuring a reliable supply of parenteral nutrition products worldwide.

Key Companies:

• Baxter International Inc.
• Braun SE
• Fresenius Kabi AG
• Grifols S.A.
• Pfizer Inc.
• Otsuka Pharmaceutical Co., Ltd.
• JW Pharmaceutical Corporation
• Sichuan Kelun Pharmaceutical Co., Ltd.
• ICU Medical, Inc.
• Viatris Inc.

Global Parenteral Nutrition Market Outlook

• Increasing demand for home parenteral nutrition is expected to accelerate the adoption of portable infusion systems and remote patient monitoring technologies.
• Advancements in personalized nutrition formulations and ready-to-use multi-chamber bags will continue to improve treatment safety and clinical efficiency.
• Growing prevalence of gastrointestinal disorders, cancer, and chronic diseases will sustain long-term demand for specialized intravenous nutritional support.
• Expansion of healthcare infrastructure and improved access to clinical nutrition therapies in emerging economies will create new growth opportunities for market participants.
• Ongoing investments in sterile manufacturing, supply chain resilience, and innovative lipid emulsions are expected to strengthen product availability and support market expansion.

Frequently Asked Questions About the Parenteral Nutrition Market